RVTY
Revvity, Inc.NYSEHealthcare$88.94+1.16%ClosedMarket Cap: $9.94B
As of 2026-04-06
Valuation
P/E (TTM)
41.15
PEG
—
P/B
1.39
P/S
3.48
EV/EBITDA
16.38
DCF Value
$115.24
FCF Yield
5.1%
Div Yield
0.3%
Margins & Returns
Gross Margin
50.2%
Operating Margin
13.0%
Net Margin
8.5%
ROE
3.2%
ROA
7.5%
ROIC
2.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $772.1M | 43.8% | $111.7M | $98.4M | $0.87 | $0.07 |
| FY 2025 | $2.86B | 53.1% | $356.6M | $241.7M | $2.08 | $0.28 |
| Q3 2025 | $698.9M | 53.6% | $81.9M | $46.7M | $0.40 | $0.07 |
| Q2 2025 | $720.3M | 54.5% | $90.8M | $55.2M | $0.47 | $0.07 |
| Q1 2025 | $664.8M | 49.2% | $88.0M | $41.4M | $0.34 | $0.07 |
| Q4 2024 | $729.4M | 49.3% | $132.3M | $95.0M | $0.78 | $0.07 |
| FY 2024 | $2.76B | 48.0% | $410.5M | $295.8M | $2.41 | $0.28 |
| Q3 2024 | $684.0M | 56.3% | $102.6M | $94.0M | $0.76 | $0.07 |
| Q2 2024 | $691.7M | 55.7% | $101.5M | $79.1M | $0.64 | $0.07 |
| Q1 2024 | $649.9M | 54.6% | $74.1M | $27.7M | $0.22 | $0.07 |
| Q4 2023 | $695.9M | 42.2% | $99.4M | $102.7M | $0.83 | $0.07 |
| FY 2023 | $2.75B | 48.1% | $399.5M | $-118.4M | $-0.95 | $0.28 |